00Read later0Read MoreAmgen’s Imdelltra Combination Reduced the Risk of Death by 58% in a Phase 3 Trial for Small-Cell Lung CancerStocks - Investing and trading for all·foodie_2598·about 20 hours ago#4wgrQXTx#stocks#redditstocks#amgen#imfinzi#results+6 more🧰Tag tools✨Add tagAmgen ($AMGN) announced Phase 3 trial results showing that combining Imdelltra with Imfinzi reduced the risk of death by 58% in patients with small-cell lung cancer, compared with Imfinzi alone.… Read more15s